LMNA and familial dilated cardiomyopathy: In a study by Roncarati et al., the presence of the TTN variant and the LMNA mutation carriers modified DCM patients’ clinical course and disease severity, with double heterozygotes requiring earlier heart transplantation (four individuals) compared with those only harboring the LMNA mutation alone.